Health-related quality of life and fear of progression in individuals with Li-Fraumeni syndrome

被引:2
作者
Kiermeier, Senta [1 ]
Schott, Sarah [2 ]
Nees, Juliane [2 ]
Dutzmann, Christina [3 ]
Struewe, Farina [3 ]
Kratz, Christian P. [3 ]
Sauer, Christina [4 ]
Fleischer, Anna [1 ]
Keymling, Myriam [5 ]
Maatouk, Imad [1 ]
机构
[1] Julius Maximilian Univ Wurzburg, Dept Internal Med 2, Sect Psychosomat Med Psychotherapy & Psychooncol, Wurzburg, Germany
[2] Univ Hosp Heidelberg, Dept Gynecol & Obstet, Heidelberg, Germany
[3] Hannover Med Sch, Dept Pediat Hematol & Oncol, Hannover, Germany
[4] Univ Hosp Heidelberg, Dept Gen Internal Med & Psychosomat, Heidelberg, Germany
[5] German Canc Res Ctr, Dept Radiol, Heidelberg, Germany
关键词
distress; fear of progression; Li-Fraumeni syndrome; mental health; psychosocial; quality of life; TP53 MUTATION CARRIERS; HEREDITARY CANCER; OVARIAN-CANCER; SURVEILLANCE; RECURRENCE; VALIDATION; BURDEN; BREAST; FAMILIES; DISEASE;
D O I
10.1002/jgc4.1859
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Li-Fraumeni syndrome (LFS) is a rare autosomal dominant cancer predisposition syndrome associated with a highly elevated lifetime cancer risk. This and the recommended intense surveillance program represent a large psychological burden on families. In order to develop targeted psychosocial interventions, we conducted a needs assessment. Adults (>= 18 years) with LFS were included via regular hospital visits and online support groups and newsletters. Individuals filled out a questionnaire addressing among others: fear of progression (FoP-questionnaire, short-form), health-related quality of life (HRQoL, Short-Form Health Survey-12), distress (National Comprehensive Cancer Network distress thermometer), perceived cancer risk, and aspects of surveillance adherence. Collecting data over a 14-month period (March 2020 - June 2021), 70 adults were recruited (female = 58, 82.9%; mean age = 41.53 years). With mean mental component scores (MCS) of 42.28 (SD = 10.79), and physical component scores (PCS) of 48.83 (SD = 10.46), HRQoL was low in 34.8% (physical) and 59.4% (mental) of individuals when applying a mean cut-off of 45.4 (PCS) and 47.5 (MCS) to indicate poor HRQoL. High levels of FoP and distress were present in 68.6% and 69.1% of the participants, respectively. Performing a multiple linear regression on MCS and PCS, no sociodemographic variable was shown to be significant. FoP (beta = -0.33, p < 0.05) and distress (beta = -0.34, p < 0.05) were significantly associated with MCS. Individuals in our sample were burdened more than expected, with the majority reporting low levels of (mental) HRQoL, high distress, and FoP. Psychosocial support is necessary to help individuals with LFS (survivors as well as "previvors") increase their HRQoL, as it is crucial to survival.
引用
收藏
页数:10
相关论文
共 48 条
  • [1] Should Genetic Testing be Offered for Children? The Perspectives of Adolescents and Emerging Adults in Families with Li-Fraumeni Syndrome
    Alderfer, Melissa A.
    Lindell, Robert B.
    Viadro, Claire I.
    Zelley, Kristin
    Valdez, Jessica
    Mandrell, Belinda
    Ford, Carol A.
    Nichols, Kim E.
    [J]. JOURNAL OF GENETIC COUNSELING, 2017, 26 (05) : 1106 - 1115
  • [2] Revisiting tumor patterns and penetrance in germline TP53 mutation carriers: temporal phases of Li-Fraumeni syndrome
    Amadou, Amina
    Achatz, Maria I. Waddington
    Hainaut, Pierre
    [J]. CURRENT OPINION IN ONCOLOGY, 2018, 30 (01) : 23 - 29
  • [3] Genetic counselling of young women with breast cancer for Li-Fraumeni syndrome: a nationwide survey on the experiences and attitudes of genetics professionals
    Bakhuizen, J. J.
    Velthuizen, M. E.
    Stehouwer, S.
    Bleiker, E. M.
    Ausems, M. G.
    [J]. FAMILIAL CANCER, 2019, 18 (02) : 231 - 239
  • [4] Please Test My Child for a Cancer Gene, but Don't Tell Her
    Bester, Johan
    Sabatello, Maya
    van Karnebeek, Clara D. M.
    Lantos, John D.
    [J]. PEDIATRICS, 2018, 141 (04)
  • [5] The faster the better?uA systematic review on distress in the diagnostic phase of suspected cancer, and the influence of rapid diagnostic pathways
    Brocken, Pepijn
    Prins, Judith B.
    Dekhuijzen, P. N. Richard
    van der Heijden, Henricus F. M.
    [J]. PSYCHO-ONCOLOGY, 2012, 21 (01) : 1 - 10
  • [6] Determinants of quality of life among long-term breast cancer survivors
    Chu, Wai-on
    Dialla, Pegdwende Olivia
    Roignot, Patrick
    Bone-Lepinoy, Marie-Christine
    Poillot, Marie-Laure
    Coutant, Charles
    Arveux, Patrick
    Dabakuyo-Yonli, Tienhan Sandrine
    [J]. QUALITY OF LIFE RESEARCH, 2016, 25 (08) : 1981 - 1990
  • [7] Fear of disease progression in carriers of the m.3243A&gt;G mutation
    Custers, Jose A. E.
    de Laat, Paul
    Koene, Saskia
    Smeitink, Jan
    Janssen, Mirian C. H.
    Verhaak, Christianne
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2018, 13
  • [8] "It's not if I get cancer, it's when I get cancer": BRCA-positive patients' (un)certain health experiences regarding hereditary breast and ovarian cancer risk
    Dean, Marleah
    [J]. SOCIAL SCIENCE & MEDICINE, 2016, 163 : 21 - 27
  • [9] Dinkel A., 2018, VERHALTENSTHERAPEI V, V39, P198
  • [10] Drixler K, 2020, Z PSYCHOSOM MED PSYC, V66, P272, DOI 10.13109/zptm.2020.66.3.272